10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Phenotyping of autoreactive B cells with labeled nucleosomes in 56R transgenic mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The phenotypic characterization of self-reactive B cells producing autoantibodies is one of the challenges to get further insight in the physiopathology of autoimmune diseases. We took advantage of our previously developed flow cytometry method, using labeled nucleosomes, prominent autoantigens in systemic lupus erythematosus, to analyze the phenotype of self-reactive B cells in the anti-DNA B6.56R mouse model. We showed that splenic anti-nucleosome B cells express mostly kappa light chains and harbor a marginal zone phenotype. Moreover, these autoreactive B cells fail to acquire a germinal center phenotype and are less abundant in the transitional T3 compartment. In conclusion, the direct detection of autoreactive B cells helped determine their phenotypic characteristics and provided a more direct insight into the B cell tolerance process in B6.56R mice. This method constitutes an interesting new tool to study the mechanisms of B cell tolerance breakdown in B6.56R mice crossed with autoimmune prone models.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: not found
          • Article: not found

          Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mechanisms of central tolerance for B cells

            Receptor editing and apoptosis have crucial roles in promoting the central tolerance of B cells to self-antigens. Defects of these processes can result in autoimmunity or immunodeficiency disease in humans and mice.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals

              Only mature B lymphocytes can enter the lymphoid follicles of spleen and lymph nodes and thus efficiently participate in the immune response. Mature, long-lived B lymphocytes derive from short-lived precursors generated in the bone marrow. We show that selection into the mature pool is an active process and takes place in the spleen. Two populations of splenic B cells were identified as precursors for mature B cells. Transitional B cells of type 1 (T1) are recent immigrants from the bone marrow. They develop into the transitional B cells of type 2 (T2), which are cycling and found exclusively in the primary follicles of the spleen. Mature B cells can be generated from T1 or T2 B cells.
                Bookmark

                Author and article information

                Contributors
                pauline.soulas@ibmc-cnrs.unistra.fr
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                16 October 2017
                16 October 2017
                2017
                : 7
                : 13232
                Affiliations
                [1 ]ISNI 0000 0004 0638 0833, GRID grid.465534.5, CNRS UPR 3572 “Immunopathology and Therapeutic Chemistry”/Laboratory of Excellence Médalis, Institute of Molecular and Cellular Biology (IBMC), ; Strasbourg, France
                [2 ]ISNI 0000 0001 2177 138X, GRID grid.412220.7, Department of Clinical Immunology and Internal Medicine, National Reference Center for Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, ; Strasbourg, France
                [3 ]ISNI 0000 0001 2157 9291, GRID grid.11843.3f, UFR Médecine, Université de Strasbourg, ; Strasbourg, France
                [4 ]ISNI 0000 0001 2157 9291, GRID grid.11843.3f, UFR Sciences pharmaceutiques, Université de Strasbourg, ; Illkirch-Graffenstaden, France
                Author information
                http://orcid.org/0000-0002-2058-4811
                Article
                13422
                10.1038/s41598-017-13422-z
                5643551
                29038433
                10e71579-8d7f-4db8-9899-77ba62607f07
                © The Author(s) 2017

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 1 August 2017
                : 21 September 2017
                Categories
                Article
                Custom metadata
                © The Author(s) 2017

                Uncategorized
                Uncategorized

                Comments

                Comment on this article